Arrien Pharmaceuticals Private
Arrien Pharmaceuticals is a drug discovery and development company focused on small molecule-targeted therapeutics. Their main goal is to target cell signaling pathways in order to develop treatments for neurodegenerative, cancer, inflammatory, and metabolic diseases. They have successfully identified pre-clinical stage programs for diseases such as Parkinson's, Alzheimer's, cancer, rheumatoid arthritis, type 2 diabetes, and obesity. Arrien Pharmaceuticals utilizes a proprietary platform for their drug discovery efforts.
Industry:
PharmTech
Technology:
Data-driven Technologies
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Headquarters:
Ansonia, Connecticut, United States
Employee Number:
1-10
Total Funding:
$1.7M
Founded Date:
2011
Last Funding Type:
Venture - Series Unknown